IL152018A0 - Dna encoding mammalian sphingosine kinase type 2 isoforms, proteins encoded by said dna and pharmaceutical compositions containing the same - Google Patents

Dna encoding mammalian sphingosine kinase type 2 isoforms, proteins encoded by said dna and pharmaceutical compositions containing the same

Info

Publication number
IL152018A0
IL152018A0 IL15201801A IL15201801A IL152018A0 IL 152018 A0 IL152018 A0 IL 152018A0 IL 15201801 A IL15201801 A IL 15201801A IL 15201801 A IL15201801 A IL 15201801A IL 152018 A0 IL152018 A0 IL 152018A0
Authority
IL
Israel
Prior art keywords
dna
isoforms
sphingosine kinase
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL15201801A
Other languages
English (en)
Original Assignee
Sankyo Co
Univ Georgetown
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co, Univ Georgetown filed Critical Sankyo Co
Priority claimed from PCT/US2001/009664 external-priority patent/WO2001074837A1/en
Publication of IL152018A0 publication Critical patent/IL152018A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL15201801A 2000-04-03 2001-03-26 Dna encoding mammalian sphingosine kinase type 2 isoforms, proteins encoded by said dna and pharmaceutical compositions containing the same IL152018A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19431800P 2000-04-03 2000-04-03
PCT/US2001/009664 WO2001074837A1 (en) 2000-04-03 2001-03-26 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof

Publications (1)

Publication Number Publication Date
IL152018A0 true IL152018A0 (en) 2003-04-10

Family

ID=22717111

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15201801A IL152018A0 (en) 2000-04-03 2001-03-26 Dna encoding mammalian sphingosine kinase type 2 isoforms, proteins encoded by said dna and pharmaceutical compositions containing the same
IL152018A IL152018A (en) 2000-04-03 2002-09-30 DNA encoding isoforms of sphingosine kinase form 2 mammals, proteins encoded by DNA and pharmaceutical preparations containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL152018A IL152018A (en) 2000-04-03 2002-09-30 DNA encoding isoforms of sphingosine kinase form 2 mammals, proteins encoded by DNA and pharmaceutical preparations containing them

Country Status (12)

Country Link
EP (2) EP2110379A3 (de)
CN (1) CN1443192A (de)
AT (1) ATE449783T1 (de)
AU (1) AU2001251002B2 (de)
BR (1) BR0109827A (de)
CZ (1) CZ20023282A3 (de)
DE (1) DE60140605D1 (de)
IL (2) IL152018A0 (de)
NO (1) NO20024727L (de)
PL (1) PL365523A1 (de)
RU (1) RU2002126264A (de)
ZA (1) ZA200207930B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106975071B (zh) * 2017-02-17 2019-10-29 苏州大学 一种治疗缺血性脑中风的Tat-SPK2肽及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2329124A1 (en) * 1998-05-26 1999-12-02 Office Of The Dean Of Research And Graduate Education Sphingosine kinase, cloning, expression and methods of use
WO2000052173A2 (en) * 1999-03-02 2000-09-08 Nps Allelix Corp. Cloned human sphingosine kinase homologues

Also Published As

Publication number Publication date
EP2110379A3 (de) 2010-07-28
DE60140605D1 (de) 2010-01-07
EP2110379A2 (de) 2009-10-21
NO20024727D0 (no) 2002-10-02
BR0109827A (pt) 2004-07-06
AU2001251002B2 (en) 2005-10-20
CN1443192A (zh) 2003-09-17
NO20024727L (no) 2002-12-03
RU2002126264A (ru) 2004-03-20
EP1268509B1 (de) 2009-11-25
EP1268509A4 (de) 2004-09-22
ZA200207930B (en) 2004-01-27
IL152018A (en) 2008-12-29
ATE449783T1 (de) 2009-12-15
PL365523A1 (en) 2005-01-10
EP1268509A1 (de) 2003-01-02
CZ20023282A3 (cs) 2003-05-14

Similar Documents

Publication Publication Date Title
EP0957903A4 (de) Pharmazeutische zubereitungen und verfahren
CA2189250A1 (en) Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
BG104599A (en) Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
IL152659A (en) Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer
UA66417C2 (en) Recombinant adenovirus affecting canines, pharmaceutical composition
MY101887A (en) A novel human physiologically active polypeptide.
ATE393831T1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
MY132496A (en) Inhibitors of p38
MY117696A (en) INHIBITORS OF p38
EP1310558A3 (de) Stabiele bakterizide Proteine, welche die Permeabilität erhöhen und pharmazeutische Zusammensetzungen, diese enthaltend
BR9811956B1 (pt) naftiridinonas e composição farmacêutica compreendendo as mesmas.
DK0679092T3 (da) Cytokindæmpende midler
CA2026915A1 (en) Stem cell factor
IL114904A0 (en) Adenovirus comprising a gene encoding glutathione peroxidase
GB9806632D0 (en) Peptide factor
WO1997026322A3 (en) Methods and compositions for inhibiting hexokinase
LTIP610A (en) Inhibitors of cells proliferation, pharmaceutical composition and method for preparation of compounds
FR2724320B1 (fr) Nouvel implant pour le traitement des maladies acquises
IL152018A0 (en) Dna encoding mammalian sphingosine kinase type 2 isoforms, proteins encoded by said dna and pharmaceutical compositions containing the same
MX9800049A (es) Antraquinonas mono- y disulfo-substituidas y su uso para el tratamiento de trastornos de la matriz del hueso.
WO2001083722A3 (en) Enzymes useful for treating and methods for treating mps-vi and cells lines for producing such enzymes recombinantly
NZ228208A (en) Eglin compounds (hurudin) and protease inhibitor pharmaceutical compositions
DE60034874D1 (de) Interne ribosom eintrittstelle (ires), vektor der diesen enthaltet und dessen therapeutische verwendung
MY103584A (en) 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it
MY129421A (en) INHIBITORS OF p38